News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
214 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17936)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (92)
5 (188)
6 (200)
7 (159)
8 (127)
11 (214)
12 (192)
13 (176)
14 (157)
15 (129)
18 (164)
19 (204)
20 (160)
21 (146)
22 (91)
25 (185)
26 (203)
27 (147)
28 (161)
29 (110)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
5
6
7
8
11
12
13
14
15
18
19
20
21
22
25
26
27
28
29
Drug Development
Eisai Inc. Release: Combination Of Lenvatinib And Pembrolizumab Results In Notable Response Rates For Patients With Advanced Renal Cell Carcinoma Based On Interim Analysis Of Ongoing Phase Ib/II Trial
September 11, 2017
·
16 min read
Drug Development
Novartis AG Phase III Study Demonstrates Adjuvant Tafinlar + Mekinist Reduced The Risk Of Disease Recurrence By 53% In Patients With Resected BRAF V600 Mutation-Positive Melanoma
September 11, 2017
·
18 min read
Business
QPharma, Inc. Names Badal Shah As Managing Director, KOL And Targeting
September 11, 2017
·
2 min read
Drug Development
Lycera Presents Encouraging Safety Results From Phase I ARGON Study Of LYC-55716 At The European Society For Medical Oncology (ESMO) Congress
September 11, 2017
·
4 min read
Drug Development
Deciphera Reports Updated Data From Ongoing Phase I Clinical Study Of DCC-2618 At The European Society Of Medical Oncology 2017 Congress
September 11, 2017
·
4 min read
Drug Development
Zymeworks Presents Additional Safety And Anti-Tumor Activity Data From The Ongoing Phase 1 Study Of ZW25 At The European Society For Medical Oncology 2017 Congress (“ESMO”)
September 11, 2017
·
9 min read
Drug Development
Syros Pharma Presents PK And PD Data At ESMO For SY-1425, Its First-In-Class Selective Rara Agonist, In Genomically Defined AML And MDS Patients
September 11, 2017
·
8 min read
Drug Development
Blueprint Medicines Announces New Data From Ongoing Phase I Clinical Trial Of BLU-554 In Patients With Advanced Hepatocellular Carcinoma
September 11, 2017
·
11 min read
Pharm Country
OZMOSI Launches A Global Clinical Trials Database To Transform Drug Development Forecasting
September 11, 2017
·
3 min read
Drug Development
GlaxoSmithKline Release: Positive Results From Pioneering Salford Lung Study In Asthma Published In The Lancet, And Presented At European Respiratory Congress
September 11, 2017
·
19 min read
Previous
17 of 22
Next